These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18424014)

  • 1. Proteasome inhibition as a novel therapy in treating rheumatoid arthritis.
    Brun J
    Med Hypotheses; 2008; 71(1):65-72. PubMed ID: 18424014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
    Khan S
    Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
    Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
    Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibition for treatment of multiple myeloma: clinical update.
    Stadtmauer EA
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S10-5. PubMed ID: 19795531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving disease biology from the lab to the clinic.
    Anderson KC
    Cancer; 2003 Feb; 97(3 Suppl):796-801. PubMed ID: 12548578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signalling in rheumatoid arthritis.
    Sen M
    Rheumatology (Oxford); 2005 Jun; 44(6):708-13. PubMed ID: 15705634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibition as novel treatment strategy in leukaemia.
    Vink J; Cloos J; Kaspers GJ
    Br J Haematol; 2006 Aug; 134(3):253-62. PubMed ID: 16787504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.
    von Metzler I; Heider U; Mieth M; Lamottke B; Kaiser M; Jakob C; Sezer O
    Exp Cell Res; 2009 Aug; 315(14):2471-8. PubMed ID: 19410573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors in cancer therapy.
    Orlowski RZ
    Methods Mol Biol; 2005; 301():339-50. PubMed ID: 15917644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibitors in lung cancer.
    Scagliotti G
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):177-89. PubMed ID: 16427303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition and multiple myeloma.
    Kanagasabaphy P; Morgan GJ; Davies FE
    Curr Opin Investig Drugs; 2007 Jun; 8(6):447-51. PubMed ID: 17621873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis.
    Yamanishi Y; Boyle DL; Green DR; Keystone EC; Connor A; Zollman S; Firestein GS
    Arthritis Res Ther; 2005; 7(1):R12-8. PubMed ID: 15642132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibitors: poisons and remedies.
    Meiners S; Ludwig A; Stangl V; Stangl K
    Med Res Rev; 2008 Mar; 28(2):309-27. PubMed ID: 17880010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinases as targets in rheumatoid arthritis.
    Tristano AG
    Int Immunopharmacol; 2009 Jan; 9(1):1-9. PubMed ID: 18848912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats.
    Yannaki E; Papadopoulou A; Athanasiou E; Kaloyannidis P; Paraskeva A; Bougiouklis D; Palladas P; Yiangou M; Anagnostopoulos A
    Arthritis Rheum; 2010 Nov; 62(11):3277-88. PubMed ID: 20722034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibitors in pediatric cancer treatment.
    Bachmann AS
    Hawaii Med J; 2008 Sep; 67(9):247-9. PubMed ID: 18853901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma.
    Bersani F; Taulli R; Accornero P; Morotti A; Miretti S; Crepaldi T; Ponzetto C
    Eur J Cancer; 2008 Apr; 44(6):876-84. PubMed ID: 18342500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway.
    Pattacini L; Casali B; Boiardi L; Pipitone N; Albertazzi L; Salvarani C
    Rheumatology (Oxford); 2007 Aug; 46(8):1252-7. PubMed ID: 17526929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of the proteasome in leukaemia.
    McCloskey SM; McMullin MF; Walker B; Irvine AE
    Hematol Oncol; 2008 Jun; 26(2):73-81. PubMed ID: 18324639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteasome: a worthwhile target for the treatment of solid tumours?
    Milano A; Iaffaioli RV; Caponigro F
    Eur J Cancer; 2007 May; 43(7):1125-33. PubMed ID: 17379504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.